Oxidant-mediated injury is an important contributor to organ dysfunction in
the critically ill patient. Based on the ability of antioxidants to neutra
lize oxidant damage and to inhibit intracellular signaling pathways, these
agents may be useful in the management of patients. While animal studies ha
ve consistently shown beneficial effects of antioxidant treatment, the bene
fits observed in human studies have been less compelling. Future studies sh
ould include larger sample sizes, better patient selection, improved defini
tion of primary endpoints, and possible alternate strategies for antioxidan
t delivery.